VintaBio, a biotech manufacturer specializing in high-yield, high-purity viral vectors for gene therapy, today presented data further demonstrating the advantages and productivity of its proprietary ...

Gene therapy is at the cutting edge of medicine, with exciting new products being developed and used to treat a wide variety ...

PackGene Biotech, Inc. announced today six presentations at the American Society of Gene & Cell Therapy (ASGCT) 28th annual meeting in New Orleans, May 13-17, highlighting the company's comprehensive ...

Roughly two years after securing a former Novartis facility in Illinois to support its CAR-T cancer treatments Breyanzi and ...

and user of viral vectors. However, it is far from a unique opinion in the sector. Most CDMOs working in the space recognize the need for better vector production technologies and have been making ...

Mass photometry enables rapid, purification-free quantification of rAAV vectors, offering a faster solution for gene therapy ...

May 2025 - eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, has entered into a strategic partnership with KU Leuven, one of Europe’s leading academic ...

Recombinant adeno-associated virus (rAAV) is a promising vector for delivering therapeutic ... here should speed up the manufacturing process, with positive effects for patients in need of genetic ...

ReiThera, the Italian CDMO company specialized in the development and manufacturing of genetic vaccines and advanced therapies, is pleased to announce its participation in the 27th Annual Meeting of ...

Gene therapy developed and delivered in 10 months for child with IRF2BPL mutation; first treatment administered at Weill ...